Publicaciones en colaboración con investigadores/as de Fundación Jiménez Díaz (17)

2023

  1. Recommendations of the Spanish Society of Nephrology for the management of mineral and bone metabolism disorders in patients with chronic kidney disease: 2021 (SEN-MM)

    Nefrologia, Vol. 43, pp. 1-36

2022

  1. RICORS2040: The need for collaborative research in chronic kidney disease

    Clinical Kidney Journal, Vol. 15, Núm. 3, pp. 372-387

  2. Recommendations of the Spanish Society of Nephrology for the management of mineral and bone metabolism disorders in patients with chronic kidney disease: 2021 (SEN-MM)

    Nefrologia, Vol. 42, pp. 1-37

  3. Sodium-glucose co-transporter-2 inhibitors increase Klotho in patients with diabetic kidney disease: A clinical and experimental study

    Biomedicine and Pharmacotherapy, Vol. 154

2021

  1. Control of phosphorus and prevention of fractures in the kidney patient

    Nefrologia, Vol. 41, Núm. 1, pp. 7-14

  2. Interleuquina-17A: posible mediador y diana terapéutica en la hipertensión

    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, Vol. 41, Núm. 3, pp. 244-257

  3. Mortality in hemodialysis patients with covid-19, the effect of paricalcitol or calcimimetics

    Nutrients, Vol. 13, Núm. 8

  4. Optimizing the timing of nephrology referral for patients with diabetic kidney disease

    Clinical Kidney Journal, Vol. 14, Núm. 1, pp. 5-8

  5. Setting up a cardiorenal clinic. Consensus document of the cardiorenal working groups of the Spanish Society of Cardiology and the Spanish Society of Nephrology

    REC: CardioClinics, Vol. 56, Núm. 4, pp. 284-295

2020

  1. Association of a single nucleotide polymorphism combination pattern of the Klotho gene with non-cardiovascular death in patients with chronic kidney disease

    Clinical Kidney Journal, Vol. 13, Núm. 6, pp. 1017-1024

2019

  1. Association of candidate gene polymorphisms with chronic kidney disease: Results of a case-control analysis in the NEFRONA cohort

    Frontiers in Genetics, Vol. 10, Núm. FEB

  2. Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation and Study of Diabetic Nephropathy with Atrasentan: What was learned about the treatment of diabetic kidney disease with canagliflozin and atrasentan?

    Clinical Kidney Journal, Vol. 12, Núm. 3, pp. 313-321

2018

  1. Pharmacological interactions of phosphate binders

    Nefrologia, Vol. 38, Núm. 6, pp. 573-578

2017

  1. Factors influencing pathological ankle-brachial index values along the chronic kidney disease spectrum: The NEFRONA study

    Nephrology Dialysis Transplantation, Vol. 32, Núm. 3, pp. 513-520

2016

  1. Implications of Fibroblast growth factor/Klotho system in glucose metabolism and diabetes

    Cytokine and Growth Factor Reviews

2015

  1. Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease

    Nephrology Dialysis Transplantation, Vol. 30, Núm. 7, pp. 1176-1185

  2. Horizon 2020 in diabetic kidney disease: The clinical trial pipeline for add-on therapies on top of renin angiotensin system blockade

    Journal of Clinical Medicine, Vol. 4, Núm. 6, pp. 1325-1347